Evonik (0QDS) Share Forecast & Price Target

Compare

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QDS Analyst Ratings

Hold

3 Buy

9 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Evonik

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QDS Stock 12 Month Forecast

Average Price Target

€18.08

▲(22.41% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Evonik in the last 3 months. The average price target is €18.08 with a high forecast of €22.00 and a low forecast of €15.00. The average price target represents a 22.41% change from the last price of €14.77.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"€14","23":"€23","16.25":"€16.25","18.5":"€18.5","20.75":"€20.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€22.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€18.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,16.25,18.5,20.75,23],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.41,16.84,17.27,17.7,18.13,18.56,18.990000000000002,19.42,19.85,20.28,20.71,21.14,21.57,{"y":22,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.41,16.53846153846154,16.666923076923077,16.795384615384616,16.923846153846153,17.052307692307693,17.18076923076923,17.30923076923077,17.437692307692306,17.566153846153846,17.694615384615382,17.823076923076922,17.951538461538462,{"y":18.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.41,16.301538461538463,16.193076923076923,16.084615384615386,15.976153846153846,15.867692307692307,15.759230769230768,15.650769230769232,15.542307692307693,15.433846153846154,15.325384615384616,15.216923076923077,15.108461538461539,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.87,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.07,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.31,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.8,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.17,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.95,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.82,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.48,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.88,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.19,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.52,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€22.00

Average Price Target€18.08

Lowest Price Target€15.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Martin Roediger

Kepler Capital

€18.1→€15.9

Hold

7.65%

Upside

Reiterated

09/26/25

Kepler Capital Sticks to Its Hold Rating for Evonik (0QDS)

Oliver Schwarz

Warburg Research

€22.7→€20.4

Hold

38.12%

Upside

Reiterated

09/26/25

Evonik (0QDS) Gets a Hold from Warburg Research

Peter Spengler

DZ BANK AG

―

Hold

―

Downgraded

09/26/25

DZ BANK AG downgrades Evonik (0QDS) to a Hold

Georgina Fraser CFA

Goldman Sachs

€19→€16.5

Hold

11.71%

Upside

Reiterated

09/26/25

Goldman Sachs Reaffirms Their Hold Rating on Evonik (0QDS)

Sebastian Bray

Berenberg Bank

€18→€16

Hold

8.33%

Upside

Reiterated

09/26/25

Berenberg Bank Keeps Their Hold Rating on Evonik (0QDS)

Chetan Udeshi

J.P. Morgan

€21.5→€20

Buy

35.41%

Upside

Reiterated

09/26/25

J.P. Morgan Keeps Their Buy Rating on Evonik (0QDS)

Geoff Haire

UBS

€17→€15

Hold

1.56%

Upside

Reiterated

09/26/25

UBS Keeps Their Hold Rating on Evonik (0QDS)

Thomas Wrigglesworth

Morgan Stanley

€17.8

Sell

20.51%

Upside

Reiterated

09/25/25

Morgan Stanley Keeps Their Sell Rating on Evonik (0QDS)

Chris Counihan

Jefferies

€16.4

Hold

11.04%

Upside

Reiterated

09/25/25

Jefferies Remains a Hold on Evonik (0QDS)

Virginie Boucher-Ferte

Deutsche Bank

€22→€16

Hold

8.33%

Upside

Downgraded

09/24/25

Evonik (0QDS) was downgraded to a Hold Rating at Deutsche Bank

Sebastian Satz

Citi

€23→€22

Buy

48.95%

Upside

Reiterated

08/07/25

Citi Reaffirms Their Buy Rating on Evonik (0QDS)

Dorian Reaxon

TR | OpenAI - 4o

€19.5→€19

Hold

28.64%

Upside

Reiterated

07/29/25

AI Generated ArticleAI Generated Article

David Symonds

Exane BNP Paribas

€22

Buy

48.95%

Upside

Initiated

07/16/25

Exane BNP Paribas Initiates a Buy Rating on Evonik (0QDS)

Andreas Heine

Stifel Nicolaus

€23

Buy

55.72%

Upside

Reiterated

03/18/25

Evonik's Strong Growth Potential and Resilience: A Buy Recommendation by Andreas Heine

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Martin Roediger

Kepler Capital

€18.1→€15.9

Hold

7.65%

Upside

Reiterated

09/26/25

Kepler Capital Sticks to Its Hold Rating for Evonik (0QDS)

Oliver Schwarz

Warburg Research

€22.7→€20.4

Hold

38.12%

Upside

Reiterated

09/26/25

Evonik (0QDS) Gets a Hold from Warburg Research

Peter Spengler

DZ BANK AG

―

Hold

―

Downgraded

09/26/25

DZ BANK AG downgrades Evonik (0QDS) to a Hold

Georgina Fraser CFA

Goldman Sachs

€19→€16.5

Hold

11.71%

Upside

Reiterated

09/26/25

Goldman Sachs Reaffirms Their Hold Rating on Evonik (0QDS)

Sebastian Bray

Berenberg Bank

€18→€16

Hold

8.33%

Upside

Reiterated

09/26/25

Berenberg Bank Keeps Their Hold Rating on Evonik (0QDS)

Chetan Udeshi

J.P. Morgan

€21.5→€20

Buy

35.41%

Upside

Reiterated

09/26/25

J.P. Morgan Keeps Their Buy Rating on Evonik (0QDS)

Geoff Haire

UBS

€17→€15

Hold

1.56%

Upside

Reiterated

09/26/25

UBS Keeps Their Hold Rating on Evonik (0QDS)

Thomas Wrigglesworth

Morgan Stanley

€17.8

Sell

20.51%

Upside

Reiterated

09/25/25

Morgan Stanley Keeps Their Sell Rating on Evonik (0QDS)

Chris Counihan

Jefferies

€16.4

Hold

11.04%

Upside

Reiterated

09/25/25

Jefferies Remains a Hold on Evonik (0QDS)

Virginie Boucher-Ferte

Deutsche Bank

€22→€16

Hold

8.33%

Upside

Downgraded

09/24/25

Evonik (0QDS) was downgraded to a Hold Rating at Deutsche Bank

Sebastian Satz

Citi

€23→€22

Buy

48.95%

Upside

Reiterated

08/07/25

Citi Reaffirms Their Buy Rating on Evonik (0QDS)

Dorian Reaxon

TR | OpenAI - 4o

€19.5→€19

Hold

28.64%

Upside

Reiterated

07/29/25

AI Generated ArticleAI Generated Article

David Symonds

Exane BNP Paribas

€22

Buy

48.95%

Upside

Initiated

07/16/25

Exane BNP Paribas Initiates a Buy Rating on Evonik (0QDS)

Andreas Heine

Stifel Nicolaus

€23

Buy

55.72%

Upside

Reiterated

03/18/25

Evonik's Strong Growth Potential and Resilience: A Buy Recommendation by Andreas Heine

Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector

xxx

Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evonik

1 Month

xxx

Success Rate

12/23 ratings generated profit

Average Return

-1.48%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 52.17% of your transactions generating a profit, with an average return of -1.48% per trade.

3 Months

xxx

Success Rate

13/23 ratings generated profit

Average Return

+0.48%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 56.52% of your transactions generating a profit, with an average return of +0.48% per trade.

1 Year

Chetan UdeshiJ.P. Morgan

Success Rate

25/56 ratings generated profit

Average Return

-0.56%

reiterated a buy rating 4 days ago

Copying Chetan Udeshi's trades and holding each position for 1 Year would result in 44.64% of your transactions generating a profit, with an average return of -0.56% per trade.

2 Years

xxx

Success Rate

19/56 ratings generated profit

Average Return

-6.63%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 33.93% of your transactions generating a profit, with an average return of -6.63% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QDS Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QDS has received 10 Buy Ratings, 22 Hold Ratings, and 2 Sell Ratings. 0QDS average Analyst price target in the past 3 months is 18.08.

Each month's total comprises the sum of three months' worth of ratings.

0QDS Financial Forecast

0QDS Earnings Forecast

Next quarter’s earnings estimate for 0QDS is €0.33 with a range of €0.18 to €0.46. The previous quarter’s EPS was €0.34. 0QDS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 43.91% of the time in the same period. In the last calendar year 0QDS has Outperformed its overall industry.

0QDS Sales Forecast

Next quarter’s sales forecast for 0QDS is €3.48B with a range of €3.40B to €3.57B. The previous quarter’s sales results were €3.50B. 0QDS beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.88% of the time in the same period. In the last calendar year 0QDS has Outperformed its overall industry.

0QDS Stock Forecast FAQ

What is GB:0QDS’s average 12-month price target, according to analysts?

Based on analyst ratings, Evonik’s 12-month average price target is 18.08.

What is GB:0QDS’s upside potential, based on the analysts’ average price target?

Evonik has 22.41% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Evonik a Buy, Sell or Hold?

Evonik has a consensus rating of Hold, which is based on 3 buy ratings, 9 hold ratings and 1 sell ratings.

What is Evonik’s share price target?

The average share price target for Evonik is 18.08. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €22.00 ,and the lowest forecast is €15.00. The average share price target represents 22.41% Increase from the current price of €14.77.

What do analysts say about Evonik?

Evonik’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Evonik?

To buy shares of GB:0QDS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Evonik (0QDS) Share Forecast & Price Target

0QDS Analyst Ratings

0QDS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Evonik

0QDS Analyst Recommendation Trends

0QDS Financial Forecast

0QDS Earnings Forecast

0QDS Sales Forecast

0QDS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts